Evaluation of promoters for driving efficient transgene expression in neonatal porcine islets

Xenotransplantation

Volumn 14, Issue 2, 2007, Pages 119-125

  Londrigan, Sarah L ^a   Brady, Jamie L ^a   Sutherland, Robyn M ^a   Hawthorne, Wayne J ^b   Thomas, Helen E ^c   Jhala, Guarang ^c   Cowan, Peter J ^c,d   Kay, Thomas W H ^c   O'Connell, Philip J ^b   Lew, Andrew M ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Immunology Research Centre   (Australia)

Author keywords

Adenovirus; Gene expression; Neonatal pig islets; Promoters; Xenotransplantation

Indexed keywords

ELONGATION FACTOR 1ALPHA; INSULIN; LUCIFERASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR PDX 1;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE EXPRESSION; GENETIC SCREENING; H2 SYSTEM; HUMAN; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION REGULATION; H-2 ANTIGENS; HOMEODOMAIN PROTEINS; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LUCIFERASES; MICE; PEPTIDE ELONGATION FACTOR 1; PROMOTER REGIONS (GENETICS); SWINE; TRANS-ACTIVATORS; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 33947358568     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2007.00376.x     Document Type: Article

References (37)

1. RYAN EA, PATY BW, SENIOR PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
2. HIRSHBERG B, ROTHER KI, HARLAN DM. Islet transplantation: where do we stand now? Diabetes Metab Res Rev 2003; 19: 175-178.
3. NANJI SA, SHAPIRO AM. Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab 2006; 8: 15-25.
4. O'CONNELL PJ, HAWTHORNE WJ, HOLMES- WALKER DJ et al. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial. Med J Aust 2006; 184: 221-225.
5. MACKENZIE DA, HULLETT DA, SOLLINGER HW. Xenogeneic transplantation of porcine islets: an overview. Transplantation 2003; 76: 887-891.
6. VIZZARDELLI C, MOLANO RD, PILEGGI A et al. Neonatal porcine pancreatic cell clusters as a potential source for transplantation in humans: characterization of proliferation, apoptosis, xenoantigen expression and gene delivery with recombinant AAV. Xenotransplantation 2002; 9: 14-24.
7. CARDONA K, KORBUTT GS, MILAS Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304-306.
8. BARBU AR, AKUSJARVI G, WELSH N. Adenoviral-mediated transduction of human pancreatic islets: importance of adenoviral genome for cell viability and association with a deficient antiviral response. Endocrinology 2005; 146: 2406-2414.
9. BOTTINO R, LEMARCHAND P, TRUCCO M, GIANNOUKAKIS N. Gene- and cell-based therapeutics for type I diabetes mellitus. Gene Ther 2003; 10: 875-889.
10. LEIBOWITZ G, BEATTIE GM, KAFRI T et al. Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 1999; 48: 745-753.
11. GIANNOUKAKIS N, MI Z, GAMBOTTO A et al. Infection of intact human islets by a lentiviral vector. Gene Ther 1999; 6: 1545-1551.
12. SCHMIDT P, GOTO M, LE MAUFF B, ANEGON I, KORSGREN O. Adenovirus-mediated expression of human CD55 or CD59 protects adult porcine islets from complement-mediated cell lysis by human serum. Transplantation 2003; 75: 697-702.
13. MIRENDA V, CHARREAU B, SIGALLA J et al. Xenoreactivity in the pig islet to human combination: feasibility of adenovirus-mediated gene transfer into pig islets. Transplant Proc 1996; 28: 808-810.
14. CONTRERAS JL, BILBAO G, SMYTH C et al. Gene transfer of the Bcl-2 gene confers cytoprotection to isolated adult porcine pancreatic islets exposed to xenoreactive antibodies and complement. Surgery 2001; 130: 166-174.
15. CONTRERAS JL, XIE D, MAYS J et al. A novel approach to xenotransplantation combining surface engineering and genetic modification of isolated adult porcine islets. Surgery 2004; 136: 537-547.
16. BOYLE JS, SILVA A, BRADY JL, LEW AM. DNA immunization: induction of higher avidity antibody and effect of route on T-cell cytotoxicity. Proc Natl Acad Sci U S A 1997; 94: 14626-14631.
17. KIM DW, UETSUKI T, KAZIRO Y, YAMAGUCHI N, SUGANO S. Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 1990; 91: 217-223.
18. KIMURA A, ISRAEL A, LE BAIL O, KOURILSKY P. Detailed analysis of the mouse H-2 Kb promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 1986; 44: 261-272.
19. ALLISON J, CAMPBELL IL, MORAHAN G et al. Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature 1988; 333: 529-533.
20. SAMARAS SE, CISSELL MA, GERRISH K et al. Conserved sequences in a tissue-specific regulatory region of the pdx-1 gene mediate transcription in pancreatic beta cells: role for hepatocyte nuclear factor 3 beta and Pax6. Mol Cell Biol 2002; 22: 4702-4713.
21. LONDRIGAN SL, SUTHERLAND RM, BRADY JL et al. Prolonged local expression of anti-CD4 antibody by adenovirally transduced allografts can promote long-term graft survival. J Gene Med 2006; 8: 42-52.
22. HAMAGUCHI K, GASKINS HR, LEITER EH. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991; 40: 842-849.
23. KORBUTT GS, ELLIOTT JF, AO Z et al. Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest 1996; 97: 2119-2129.
24. LIU M, SHAPIRO ME. A new method for isolation of murine islets with markedly improved yields. Transplant Proc 1995; 27: 3208-3210.
25. RICORDI C, LACY PE, FINKE EH, OLACK BJ, SCHARP DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
26. ZHAN Y, BRADY JL, IRAWATY W et al. Activated macrophages require T cells for xenograft rejection under the kidney capsule. Immunol Cell Biol 2003; 81: 451-458.
27. BANGARI DS, SHUKLA S, MITTAL SK. Comparative transduction efficiencies of human and nonhuman adenoviral vectors in human, murine, bovine, and porcine cells in culture. Biochem Biophys Res Commun 2005; 327: 960-966.
28. PLESNER A, LISTON P, TAN R, KORNELUK RG, VERCHERE CB. The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. Diabetes 2005; 54: 2533-2540.
29. LAUMONIER T, POTIRON N, BOEFFARD F et al. CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression. Hum Gene Ther 2003; 14: 561-575.
30. GREY ST, ARVELO MB, HASENKAMP WM, BACH FH, FERRAN C. Adenovirus-mediated gene transfer of the anti-apoptotic protein A20 in rodent islets inhibits IL-1 beta-induced NO release. Transplant Proc 1999; 31: 789.
31. OMORI T, NISHIDA T, KOMODA H et al. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression. Xenotransplantation 2006; 13: 455-464.
32. CONTRERAS JL, WU H, SMYTH CA et al. Double genetic modification of adenovirus fiber with RGD polylysine motifs significantly enhances gene transfer to isolated human pancreatic islets. Transplantation 2003; 76: 252-261.
33. ZHU ZB, MAKHIJA SK, LU B et al. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter. Gene Ther 2004; 11: 645-648.
34. ZHENG C, BAUM BJ. Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands. Mol Ther 2005; 12: 528-536.
35. LOILER SA, CONLON TJ, SONG S et al. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver. Gene Ther 2003; 10: 1551-1558.
36. MEYER K, IRMINGER JC, MOSS LG et al. Sorting human beta-cells consequent to targeted expression of green fluorescent protein. Diabetes 1998; 47: 1974-1977.
37. HOFFMANN D, JOGLER C, WILDNER O. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters. J Gene Med 2005; 7: 1356-1366.